Perennial Investment Advisors’s DexCom DXCM Stock Holding History

Perennial Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200	Closed	-$24.8K	–	369
2023 Q4	$24.8K	Buy	+200	New	+$20.4K	﹤0.01%	339

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perennial Investment Advisors's DXCM Position: Q3 2025 in Review

Perennial Investment Advisors sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,574 shares — an estimated $225K sold.

Perennial Investment Advisors first reported a position in DXCM in Q1 2020 and held it in 22 quarters. The position peaked at $801K in Q3 2021. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Perennial Investment Advisors reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Perennial Investment Advisors sold 2,574 DexCom shares in Q3 2025, an estimated $225K.
Perennial Investment Advisors first reported a position in DexCom in Q1 2020 and held it in 22 quarters.
Perennial Investment Advisors's DexCom position peaked at $801K in Q3 2021.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Perennial Investment Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.